» Articles » PMID: 32902676

Effect of Ejaculatory Abstinence Period on Sperm DNA Fragmentation and Pregnancy Outcome of Intrauterine Insemination Cycles:  A Prospective Randomized Study

Overview
Date 2020 Sep 9
PMID 32902676
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the effect of the ejaculatory abstinence period on sperm DNA fragmentation and pregnancy rates in IUI cycles.

Methods: One hundred and twenty couples with unexplained infertility were prospectively randomized into two groups on the second day of their cycle. In group A, patients had 1-day ejaculatory abstinence period; in group B patients had 3-day ejaculatory abstinence period. Each patient was stimulated with gonadotropins, and IUI was performed. The primary outcome measure was clinical pregnancy and sperm DNA fragmentation rate.

Results: The pregnancy rate was 17.3% and 18.5% in group A and group B, respectively. No significant difference was found among the groups (p = 0.803). The sperm DNA fragmentation rate for group A (20.71 ± 11.01) and group B (23.78 ± 12.64) were almost similar (p = 0.187). The sperm DNA fragmentation rate was 24.89 ± 12.89 in pregnant couples and 21.71 ± 11.69 in non-pregnant couples (p = 0.288).

Conclusion: Even after a short abstinence period of 1 day, compared to the standard abstinence period of 3 days, pregnancy rates are similar among unexplained infertility couples undergoing ovarian stimulation and IUI.

Clinicaltrials: The study was registered at ClinicalTrials.gov with ID NCT04361292. Date of registration: 27 April 2020. The study was registered retrospectively.

Citing Articles

Impact of short abstinence versus testicular sperm on sperm DNA fragmentation: a systematic review and meta-analysis.

Kugelman N, Hochberg A, Dahan M Arch Gynecol Obstet. 2024; 310(4):1831-1843.

PMID: 39196330 DOI: 10.1007/s00404-024-07704-x.


Effects of long and short ejaculatory abstinence on sperm parameters: a meta-analysis of randomized-controlled trials.

Lo Giudice A, Asmundo M, Cimino S, Cocci A, Falcone M, Capece M Front Endocrinol (Lausanne). 2024; 15:1373426.

PMID: 38828413 PMC: 11140051. DOI: 10.3389/fendo.2024.1373426.


Controversy and Consensus on the Management of Elevated Sperm DNA Fragmentation in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations.

Farkouh A, Agarwal A, Hamoda T, Kavoussi P, Saleh R, Zini A World J Mens Health. 2023; 41(4):809-847.

PMID: 37118965 PMC: 10523126. DOI: 10.5534/wjmh.230008.


The Influence of Male Ejaculatory Abstinence Time on Pregnancy Rate, Live Birth Rate and DNA Fragmentation: A Systematic Review.

Sorensen F, Melsen L, Fedder J, Soltanizadeh S J Clin Med. 2023; 12(6).

PMID: 36983220 PMC: 10054513. DOI: 10.3390/jcm12062219.


Sperm DNA Damage and Its Relevance in Fertility Treatment: A Review of Recent Literature and Current Practice Guidelines.

Marinaro J, Schlegel P Int J Mol Sci. 2023; 24(2).

PMID: 36674957 PMC: 9860847. DOI: 10.3390/ijms24021446.


References
1.
Ombelet W, Dhont N, Thijssen A, Bosmans E, Kruger T . Semen quality and prediction of IUI success in male subfertility: a systematic review. Reprod Biomed Online. 2014; 28(3):300-9. DOI: 10.1016/j.rbmo.2013.10.023. View

2.
Ayeleke R, Asseler J, Cohlen B, Veltman-Verhulst S . Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2020; 3:CD001838. PMC: 7059962. DOI: 10.1002/14651858.CD001838.pub6. View

3.
Farquhar C, Liu E, Armstrong S, Arroll N, Lensen S, Brown J . Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial. Lancet. 2017; 391(10119):441-450. DOI: 10.1016/S0140-6736(17)32406-6. View

4.
Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H . Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999; 14(3):698-703. DOI: 10.1093/humrep/14.3.698. View

5.
Houmard B, Juang M, Soules M, Fujimoto V . Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment. Fertil Steril. 2002; 77(2):384-6. DOI: 10.1016/s0015-0282(01)02990-9. View